FDA will drop two-study requirement for new drug approvals, aiming to speed access
Read full article: FDA will drop two-study requirement for new drug approvals, aiming to speed accessThe Food and Drug Administration plans to drop its longtime standard of requiring two rigorous studies for new drug approvals.